Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New EPOC: perioperative chemotherapy with or without cetuximab in resectable colorectal liver metastases
2006-003121-82Phase 3Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Oct 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cetuximab in colorectal cancer (CRC) (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Progression-free survival. Started Oct 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2006-003121-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003121-82.